ECOSO-ICAREPD: Integrated Parkinson Care Networks: Assessment of Economics and Socials Barriers

Sponsor

University Hospital, Toulouse (Other)

Overall Status

Not yet recruiting

CT.gov ID

NCT04485468

Collaborator

(none)

100

Enrollment

Location

Anticipated Duration (Months)

16.5

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

According to the latest public health report in France, Parkinson's disease (PD) affects around 160,000 patients.

It is therefore essential to estimate the overall consumption of medical and non-medical resources by patients with PD in order to characterize the share of medical and non-medical care reimbursed by health insurance, the share of medical and non-medical care not reimbursed. by health insurance, as well as the share of formal and informal care in order to identify potential economic barriers to an optimal care path for patients with PD. It is also necessary to have information on the socio-economic characteristics and the place of residence of the resident in order to estimate the impact of these determinants on an optimal course of care.

Condition or Disease	Intervention/Treatment	Phase
Parkinson Disease	Other: Questionnaire

Detailed Description

According to the latest public health report in France, Parkinson's disease (PD) affects around 160,000 patients

The coordination of the care pathway for patients with Parkinson disease has been improved since the implementation on the national territory of 7 interregional coordination centers and 25 regional expert centers in 2012.

Health insurance reimburses 100% of direct medical and non-medical care as soon as patients are registered in Long-Term Condition n°16. However, we currently have little information about care that is not recognized for financial coverage by health insurance.

Study Design

Study Type:

Observational

Anticipated Enrollment :

100 participants

Observational Model:

Case-Only

Time Perspective:

Prospective

Official Title:

Integrated Parkinson Care Networks: Assessment of Economics and Socials Barriers to the Optimal Care Pathway for Parkinson Disease Patients

Anticipated Study Start Date :

May 9, 2021

Anticipated Primary Completion Date :

Nov 9, 2021

Anticipated Study Completion Date :

Nov 9, 2021

Arms and Interventions

Arm	Intervention/Treatment
Parkinson's disease patients Parkinson's disease patients and over 18 years old	Other: Questionnaire The patient answers the questionnaire directly following his consultation or teleconsultation or may arrange a telephone appointment with the clinical research associate a little later.

Arm

Intervention/Treatment

Parkinson's disease patients

Parkinson's disease patients and over 18 years old

Other: Questionnaire

The patient answers the questionnaire directly following his consultation or teleconsultation or may arrange a telephone appointment with the clinical research associate a little later.

Outcome Measures

Primary Outcome Measures

Identify the economic barriers to an optimal care path [Day 0]
It is the collection of the number of resources consumed and the remainder to be borne by the patient as well as the number of hours of informal help that will be valued using the replacement cost approach.

Secondary Outcome Measures

Identify and quantify the cost of the care pathway for patients with Parkinson's disease [Day 0]
it is the quantification of the number of resources consumed and identification of the unit costs for each type of resources consumed.
identify socio-economic determinants [Day 0]
identify the socio-economic and territorial determinants that could have an impact on an optimal care path.

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

Patients with Parkinson's disease of any stage of severity
Patients over 18 years of age
Patients living at home
Patient consultant at the expert center Parkinson's at Toulouse University Hospital

Exclusion Criteria:

Pregnant and lactating woman
Patient under guardianship, curatorship or safeguard of justice
Person who does not understand French to be able to answer the questionnaire
Patient who participated or participated in the iCare PD project

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	CHU de Toulouse	Toulouse		France	31059

Sponsors and Collaborators

University Hospital, Toulouse

Investigators

Principal Investigator: Olivier Rascol, University Hospital, Toulouse

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

University Hospital, Toulouse

ClinicalTrials.gov Identifier:

NCT04485468

Other Study ID Numbers:

RC31/20/0184

First Posted:

Jul 24, 2020

Last Update Posted:

Apr 9, 2021

Last Verified:

Apr 1, 2021

Individual Participant Data (IPD) Sharing Statement:

Plan to Share IPD:

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Keywords provided by University Hospital, Toulouse

Parkinson Disease,

Socio-economic

Additional relevant MeSH terms:

Parkinson Disease

Study Results

No Results Posted as of Apr 9, 2021